TY  - JOUR
AU  - Domínguez Casas, Lucía C.
AU  - Díaz Valle, David
AU  - Blanco, Ricardo
PY  - 2020
DO  - 10.1016/j.semarthrit.2020.03.023
SN  - 0049-0172
UR  - https://hdl.handle.net/20.500.14352/111926
T2  - Semininars in Arthritis and Rheumatism
AB  - Purpose: We assessed the efficacy and safety of biologic therapy in severe and refractory Peripheral Ulcerative Keratitis (PUK). Design: Open-label multicenter study of biologic-treated patients with severe PUK refractory to conventional...
LA  - eng
M2  - 608
PB  - Elsevier
KW  - Adalimumab
KW  - Anti-TNF therapy
KW  - BelimumabBiologic therapy in PUK
KW  - Certolizumab
KW  - Etanercept
KW  - Golimumab
KW  - Infliximab
KW  - Rituximab
KW  - Tocilizumab
TI  - Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients
TY  - journal article
VL  - 50
ER  -